Saranac Partners Ltd Sells 35,580 Shares of Trupanion, Inc. $TRUP

Saranac Partners Ltd lessened its stake in Trupanion, Inc. (NASDAQ:TRUPFree Report) by 59.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,420 shares of the financial services provider’s stock after selling 35,580 shares during the quarter. Saranac Partners Ltd owned 0.06% of Trupanion worth $1,070,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Federated Hermes Inc. bought a new position in Trupanion in the 3rd quarter valued at approximately $33,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in Trupanion during the 3rd quarter valued at $39,000. Kelleher Financial Advisors bought a new stake in shares of Trupanion in the 3rd quarter worth $74,000. PNC Financial Services Group Inc. increased its holdings in shares of Trupanion by 21.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after purchasing an additional 478 shares in the last quarter. Finally, AlphaQuest LLC raised its stake in shares of Trupanion by 16.5% in the third quarter. AlphaQuest LLC now owns 3,444 shares of the financial services provider’s stock worth $149,000 after purchasing an additional 487 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on TRUP. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Cantor Fitzgerald lowered their target price on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Wall Street Zen downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Finally, Piper Sandler decreased their price objective on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a report on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Trupanion presently has an average rating of “Hold” and a consensus target price of $45.50.

Check Out Our Latest Report on TRUP

Insider Transactions at Trupanion

In related news, CRO Emily Dreyer sold 7,792 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total value of $219,344.80. Following the transaction, the executive owned 35,627 shares of the company’s stock, valued at approximately $1,002,900.05. This trade represents a 17.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 2,837 shares of the business’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $26.46, for a total transaction of $75,067.02. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 31,107 shares of company stock valued at $949,347. 5.42% of the stock is owned by company insiders.

Trupanion Stock Performance

TRUP stock opened at $25.68 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.69 and a quick ratio of 1.69. Trupanion, Inc. has a 1 year low of $24.50 and a 1 year high of $57.88. The company has a market cap of $1.12 billion, a P/E ratio of 57.07 and a beta of 1.62. The stock’s fifty day moving average price is $30.11 and its 200-day moving average price is $36.67.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The firm had revenue of $376.85 million for the quarter, compared to analysts’ expectations of $375.89 million. During the same quarter last year, the company posted $0.04 EPS. The firm’s revenue was up 11.7% compared to the same quarter last year. On average, equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Trupanion Company Profile

(Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Read More

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.